Celgene Corp. to pay $280M to settle cancer drug fraud suit

A New Jersey pharmaceutical company has agreed to pay $280 million to settle a federal lawsuit alleging it committed fraud promoting two cancer drugs for unapproved purposes

from ABC News: Health http://ift.tt/2eLiwgN
via HEALTH